GlassScriptPhysician profile
Lori Daughters Halderman
NPI 1548206824
$17,385.76
in general payments reported to CMS, 2019-2025
36 companies · $10K in 2025
The $10K reported for 2025 was more than what 99% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $328 · 2020: $114 · 2021: $357 · 2022: $471 · 2023: $292 · 2024: $5,510 · 2025: $10K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $15K · Food and Beverage: $716.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $15,400.00 |
| Food and Beverage | $716.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $15,400.00 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $356.67 | 2019-2024 | |
| Pfizer INC. | $260.54 | 2019-2023 | |
| Astellas Pharma US INC | $157.97 | 2023-2025 | Veozah |
| Exeltis, USA INC. | $119.62 | 2022-2024 | Slynd |
| Hologic Sales and Service, LLC | $110.43 | 2021-2025 | Aptima, Thinprep 2000 Processor |
| Lupin INC. | $95.36 | 2019-2021 | |
| Organon LLC | $83.84 | 2021-2025 | Jada System |
| Evofem Biosciences, INC. | $75.18 | 2021-2022 | |
| Minerva Surgical, INC | $59.36 | 2022-2023 | |
| Innovation Technologies INC | $58.39 | 2023-2024 | Irrisept |
| Bayer Healthcare Pharmaceuticals INC. | $52.46 | 2019-2022 | |
| Avanos Medical | $51.97 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $51.43 | 2019-2022 | |
| Becton, Dickinson and Company | $39.41 | 2021 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dilon Technologies, INC. | $37.23 | 2025 | Hemoblast Bellows |
| Sage Therapeutics, LLC | $35.72 | 2024-2025 | Zurzuvae |
| Meditrina | $30.15 | 2021-2022 | |
| Medtronic, INC. | $27.90 | 2024 | Ligasure |
| Merck Sharp & Dohme LLC | $22.62 | 2019 | |
| Coopersurgical, INC. | $22.57 | 2024 | Paragard T 380a |
| Mayne Pharma Commercial LLC | $21.50 | 2021 | |
| Axonics, INC. | $21.06 | 2023 | Bulkamid |
| Avion Pharmaceuticals | $20.21 | 2019 | |
| Dysis Medical, INC. | $19.83 | 2020 | |
| Millicent US INC | $19.77 | 2020 | |
| Exact Sciences Corporation | $19.33 | 2023 | Cologuard Collection Kit |
| Baxter Healthcare | $16.66 | 2020 | |
| Abbott Laboratories | $16.31 | 2024 | Proclaim |
| Agile Therapeutics, INC. | $16.14 | 2023 | Twirla |
| Duchesnay USA Incorporated | $14.43 | 2019 | |
| Supernus Pharmaceuticals, INC. | $14.22 | 2025 | Qelbree |
| Smith+Nephew, INC. | $13.37 | 2022 | |
| Therapeuticsmd, INC. | $13.08 | 2019 | |
| Tactile Systems Technology INC | $11.03 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$5.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lori Halderman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.